Carl Walkey

Insider Reports History

Entity
Individual
Location
C/O Neoleukin Therapeutics, Inc., 360 1616 Eastlake Avenue East, Seattle, WA
Signature
/s/ Sean Smith, Attorney-in-Fact for Carl Walkey
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carl Walkey:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Neoleukin Therapeutics, Inc. Senior Vice President Stock Option (Right to Buy) 150K Aug 2, 2022 Direct
Neoleukin Therapeutics, Inc. Senior Vice President Restricted Stock Units 55K Feb 1, 2022 Direct

Insider Reports Filed by Carl Walkey

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NLTX Neoleukin Therapeutics, Inc. Aug 2, 2022 1 $0 4 Aug 4, 2022 Senior Vice President
NLTX Neoleukin Therapeutics, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Senior Vice President
NLTX Neoleukin Therapeutics, Inc. Aug 3, 2021 1 $0 4 Aug 5, 2021 Senior Vice President
NLTX Neoleukin Therapeutics, Inc. Jun 16, 2021 1 -$6.11K 4 Jun 17, 2021 Senior Vice President
NLTX Neoleukin Therapeutics, Inc. Jun 9, 2021 1 -$7.04K 4 Jun 11, 2021 Senior Vice President
NLTX Neoleukin Therapeutics, Inc. Jun 8, 2021 1 -$6.6K 4 Jun 9, 2021 Senior Vice President
NLTX Neoleukin Therapeutics, Inc. Jun 4, 2021 1 -$6K 4 Jun 7, 2021 Senior Vice President
NLTX Neoleukin Therapeutics, Inc. May 26, 2021 1 -$6K 4 May 26, 2021 Senior Vice President
NLTX Neoleukin Therapeutics, Inc. May 19, 2021 1 -$6.38K 4 May 21, 2021 Senior Vice President
NLTX Neoleukin Therapeutics, Inc. May 12, 2021 1 -$13.3K 4 May 12, 2021 Senior Vice President